Avian influenza virus

Avian influenza (AI) viruses, commonly known as bird flu, infect a wide range of hosts, including humans and swine. The natural reservoir lies in populations of wild aquatic birds such as ducks and shorebirds. AI viruses are members of the family Orthmyxoviridae, Type A which is subdivided into categories (strains) depending on the outer proteins H (Haemagglutinin) and N (Neuraminidase). These outer proteins can be combined to create different strains, for example H5N1, H9N2. Influenza viruses have a single stranded RNA genome that is spilt into eight different segments, which are surrounded by a capsid and an envelope.

There is currently a highly pathogenic strain of avian influenza (H5N8) circulating in Europe. The strain has been confirmed in several places within the UK. There has never been a recorded case of this strain infecting humans, and although there will always be a tiny theoretical risk, this will be contained to those handling the birds. Following a period of compulsory housing, all poultry in England are to be allowed outside from Thursday 13 April 2017 following updated evidence on the risk posed by wild birds, the UK’s Chief Veterinary Officer has announced. For more information please visit the Defra website 

  • Avian influenza is a notifiable disease and should be reported.
    Please see the Defra website for advice on how to spot and report the disease.

Associated diseases:

AI strains can be categorised into 2 types;

Highly pathogenic avian influenza (HPAI) is the more serious of the two, often being fatal in birds. Clinical signs include:

  • Swollen head
  • Blue discolouration of neck and throat
  • Loss of appetite
  • Respiratory distress such as gaping beak, coughing, sneezing, gurgling, rattling
  • Diarrhoea
  • Fewer eggs laid
  • Increased mortality

Low pathogenic avian influenza (LPAI) is less serious, with the severity depending on the species of bird and whether it has other infections. Clinical signs include mild breathing problems, but affected birds will not always display these signs (for example, ducks and geese can often be asymptomatic).

Disease Transmission:

The disease spreads by direct contact or through contaminated faeces and bodily fluids. New AI virus strains are created frequently which means that there is a constant risk that one of the new strains may spread easily among people. Thankfully no recent strains of AI have been proven to spread between people, only from birds to people.

Disease prevelance:

HPAI is spread across the globe, featuring mainly in North America, Asia, Europe and West Africa. LPAI is endemic in the Middle East and South East Asia, with poultry populations being infected with strains such as H9N2. Due to the different migratory patterns of each species, it is difficult to predict where each strain will spread.

Impact for Society – what are we doing?

Avian Influenza continues to be a threat to the worldwide poultry industry. The viruses responsible for all four of the worldwide human influenza pandemics seen in the last 100 years have originated from birds. An effective control strategy for avian influenza in domesticated poultry is therefore an essential element in the protection of both bird and human populations.

Many groups at the Institute work on and around AI. Together they are researching areas such as how LPAI can change into HPAI and how bird immune systems react to the virus. This work is able to inform better diagnostics, breeding and vaccination.

 

* Image by Frederick Murphy courtesy of Public Health Image Library (PHIL)

Research papers

Hoa L N M, Tuan N A, My P H, Huong T T K, Chi N T Y, Hau Thu T T, Carrique-Mas J, Duong M T, Tho N D, Hoang N D, Thanh T L, Diep N T, Duong N V, Toan T K, Tung T S, Mai L Q, Iqbal M, Wertheim H, van Doorn H R, Bryant J E, The Vizions C (2017)

Journal of General Virology early view,
Le T T, Chang P, Benton D J, McCauley J W, Iqbal M, Cass A E G (2017)

Analytical Chemistry 89 (12), 6781-6786
Peacock T P, Benton D J, James J, Sadeyen J-R, Chang P, Sealy J E, Bryant J E, Martin S R, Shelton H, Barclay W S, Iqbal M (2017)

Journal of Virology 91 (14), e00218-17
Peacock T P, Benton D J, Sadeyen J R, Chang P, Sealy J E, Bryant J E, Martin S R, Shelton H, McCauley J W, Barclay W S, Iqbal M (2017)

Emerging Microbes and Infections 6 (3), e11
Abdelwhab E M, Hassan M K, Abdel-Moneim A S, Naguib M M, Mostafa A, Hussein I T M, Arafa A, Erfan A M, Kilany W H, Agour M G, El-Kanawati Z, Hussein H A, Selim A A, Kholousy S, El-Naggar H, El-Zoghby E F, Samy A, Iqbal M, Eid A, Ibraheem E M, Pleschka S, Veits J, Nasef S A, Beer M, Mettenleiter T C, Grund C, Ali M M, Harder T C, Hafez H M (2016)

Infection, Genetics and Evolution 40, 80-90

Trim content

® The Pirbright Institute 2017 | A company limited by guarantee, registered in England no. 559784. The Institute is also a registered charity.